Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 3710814, 10 pages
https://doi.org/10.1155/2018/3710814
Research Article

Magnetic Resonance Imaging Findings in the Muscle Tissue of Patients with Limb Girdle Muscular Dystrophy Type 2I Harboring the Founder Mutation c.545A>G in the FKRP Gene

1Department of Neurology, Peking University First Hospital, Beijing 100034, China
2Department of Radiology, Peking University First Hospital, Beijing 100034, China

Correspondence should be addressed to Yun Yuan; moc.621@2002nuynauy

Received 8 October 2017; Revised 9 April 2018; Accepted 29 April 2018; Published 29 May 2018

Academic Editor: Alfredo Conti

Copyright © 2018 Zhiying Xie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Brockington, Y. Yuva, P. Prandini et al., “Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C,” Human Molecular Genetics, vol. 10, no. 25, pp. 2851–2859, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Driss, S. Noguchi, R. Amouri et al., “Fukutin-related protein gene mutated in the original kindred limb-girdle MD 2I,” Neurology, vol. 60, no. 8, pp. 1341–1344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Poppe, L. Cree, J. Bourke et al., “The phenotype of limb-girdle muscular dystrophy type 2I,” Neurology, vol. 60, no. 8, pp. 1246–1251, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. C. A. Boito, P. Melacini, A. Vianello et al., “Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I,” JAMA Neurology, vol. 62, no. 12, pp. 1894–1899, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Richard, J.-P. Laurent, S. Cirak et al., “216th ENMC international workshop: Clinical readiness in FKRP related myopathies January 15–17, 2016 Naarden, The Netherlands,” Neuromuscular Disorders, vol. 26, no. 10, pp. 717–724, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. T. A. Willis, K. G. Hollingsworth, A. Coombs et al., “Quantitative magnetic resonance imaging in limb-girdle muscular dystrophy 2i: A multinational cross-sectional study,” PLoS ONE, vol. 9, no. 2, Article ID e90377, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Schwartz, J. M. Hertz, M. L. Sveen, and J. Vissing, “LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype,” Neurology, vol. 64, no. 9, pp. 1635–1637, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. C. Brown, S. Torelli, M. Brockington et al., “Abnormalities in α-Dystroglycan Expression in MDC1C and LGMD2I Muscular Dystrophies,” The American Journal of Pathology, vol. 164, no. 2, pp. 727–737, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Godfrey, A. R. Foley, E. Clement, and F. Muntoni, “Dystroglycanopathies: coming into focus,” Current Opinion in Genetics & Development, vol. 21, no. 3, pp. 278–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Alhamidi, V. Brox, E. Stensland, M. Liset, S. Lindal, and O. Nilssen, “Limb girdle muscular dystrophy type 2I: No correlation between clinical severity, histopathology and glycosylated α-dystroglycan levels in patients homozygous for common FKRP mutation,” Neuromuscular Disorders, vol. 27, no. 7, pp. 619–626, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Fischer, M. C. Walter, K. Kesper et al., “Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs,” Journal of Neurology, vol. 252, no. 5, pp. 538–547, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. T. A. Willis, K. G. Hollingsworth, A. Coombs et al., “Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study,” PLoS ONE, vol. 8, no. 8, Article ID e70993, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Müller, M. Krasnianski, R. Witthaut, M. Deschauer, and S. Zierz, “Dilated cardiomyopathy may be an early sign of the C826A Fukutin-related protein mutation,” Neuromuscular Disorders, vol. 15, no. 5, pp. 372–376, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Bourteel, P. Vermersch, J.-M. Cuisset et al., “Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patients,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 80, no. 12, pp. 1405–1408, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Fu, H. Yang, C. Wei et al., “FKRP mutations, including a founder mutation, cause phenotype variability in Chinese patients with dystroglycanopathies,” Journal of Human Genetics, vol. 61, no. 12, pp. 1013–1020, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. O. M. Scott, S. A. Hyde, C. Goddard, and V. Dubowitz, “Quantitation of muscle function in children: A prospective study in duchenne muscular dystrophy,” Muscle & Nerve, vol. 5, no. 4, pp. 291–301, 1982. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Stensland, S. Lindal, C. Jonsrud et al., “Prevalence, mutation spectrum and phenotypic variability in Norwegian patients with Limb Girdle Muscular Dystrophy 2I,” Neuromuscular Disorders, vol. 21, no. 1, pp. 41–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Zhang, M. Yu, J. Jiao et al., “Clinical, myopathological and genetic mutations features of limb girdle muscular dystrophy 2I,” Chinese Journal of Neurology, vol. 50, no. 4, pp. 277–282, 2017. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Harel, Y. Goldberg, S. A. Shalev, I. Chervinski, R. Ofir, and O. S. Birk, “Limb-girdle muscular dystrophy 2I: phenotypic variability within a large consanguineous Bedouin family associated with a novel FKRP mutation,” European Journal of Human Genetics, vol. 12, no. 1, pp. 38–43, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. A. J. Waclawik, S. Lindal, and A. G. Engel, “Experimental lovastatin myopathy,” Journal of Neuropathology & Experimental Neurology, vol. 52, no. 5, pp. 542–549, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Mercuri, C. Cini, A. Pichiecchio et al., “Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype,” Neuromuscular Disorders, vol. 13, no. 7-8, pp. 554–558, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Mercuri, A. Pichiecchio, S. Counsell et al., “A short protocol for muscle MRI in children with muscular dystrophies,” European Journal of Paediatric Neurology, vol. 6, no. 6, pp. 305–307, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Stramare, V. Beltrame, R. Dal Borgo et al., “MRI in the assessment of muscular pathology: A comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies,” La Radiologia Medica, vol. 115, no. 4, pp. 585–599, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Ervasti and K. P. Campbell, “A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin,” The Journal of Cell Biology, vol. 122, no. 4, pp. 809–823, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. W.-C. Liang, Y. K. Hayashi, M. Ogawa et al., “Limb-girdle muscular dystrophy type 2I is not rare in Taiwan,” Neuromuscular Disorders, vol. 23, no. 8, pp. 675–681, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Hafner, U. Bonati, A. Fischmann et al., “Skeletal muscle MRI of the lower limbs in congenital muscular dystrophy patients with novel POMT1 and POMT2 mutations,” Neuromuscular Disorders, vol. 24, no. 4, pp. 321–324, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Zheng, W. Li, J. Du et al., “The trefoil with single fruit sign in muscle magnetic resonance imaging is highly specific for dystrophinopathies,” European Journal of Radiology, vol. 84, no. 10, pp. 1992–1998, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Fu, Y. Zheng, S. Jin et al., ““Target” and “Sandwich” Signs in Thigh Muscles have High Diagnostic Values for Collagen VI-related Myopathies,” Chinese Medical Journal, vol. 129, no. 15, pp. 1811–1816, 2016. View at Publisher · View at Google Scholar
  29. N. Carboni, M. Mura, G. Marrosu et al., “Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations,” Muscle & Nerve, vol. 41, no. 4, pp. 458–463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Klein, H. Jungbluth, E. Clement et al., “Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations,” JAMA Neurology, vol. 68, no. 9, pp. 1171–1179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Mercuri, B. Talim, B. Moghadaszadeh et al., “Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1),” Neuromuscular Disorders, vol. 12, no. 7-8, pp. 631–638, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Mercuri, E. Clements, A. Offiah et al., “Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine,” Annals of Neurology, vol. 67, no. 2, pp. 201–208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Carboni, M. Mura, G. Marrosu et al., “Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation,” Neuromuscular Disorders, vol. 18, no. 4, pp. 291–298, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Mercuri, S. Counsell, J. Allsop et al., “Selective muscle involvement on magnetic resonance imaging in autosomal dominant Emery-Dreifuss muscular dystrophy,” Neuropediatrics, vol. 33, no. 1, pp. 10–14, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Jin, J. Du, Z. Wang et al., “Heterogeneous characteristics of MRI changes of thigh muscles in patients with dysferlinopathy,” Muscle & Nerve, vol. 54, no. 6, pp. 1072–1079, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Xu, Y. Zhao, J. Liu, W. Zhang, Z. Wang, and Y. Yuan, “Muscle MRI in neutral lipid storage disease with myopathy carrying mutation c.187+1G>A,” Muscle & Nerve, vol. 51, no. 6, pp. 922–927, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Zheng, L. Liu, L. Wang et al., “Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle,” Rheumatology, vol. 54, no. 6, Article ID keu422, pp. 1017–1024, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. T. A. L. Wren, S. Bluml, L. Tseng-Ong, and V. Gilsanz, “Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study.,” AJR. American journal of roentgenology, vol. 190, no. 1, pp. W8–12, 2008. View at Publisher · View at Google Scholar · View at Scopus